Fanconi's Anemia

11 registered clinical trials studyying Fanconi's Anemia.

Status	Trial	Sponsor	Phase
Completed	Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT) NCT03609814	University of California, San Francisco	—
Completed	Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients NCT03609827	University of California, San Francisco	—
Unknown	Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia NCT00006127	Dana-Farber Cancer Institute	Phase 1
Completed	Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With M NCT00005892	Fairview University Medical Center	N/A
Completed	Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With F NCT00005891	Fairview University Medical Center	N/A
Unknown	Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peri NCT00005896	University of Minnesota	Phase 1
Completed	Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hema NCT00005898	University of Minnesota	Phase 1 / Phase 2
Completed	Medical Treatment for Diamond Blackfan Anemia NCT00001749	National Heart, Lung, and Blood Institute (NHLBI)	Phase 2
Completed	Stem Cell Transplantation (SCT) for Genetic Diseases NCT00004378	National Center for Research Resources (NCRR)	N/A
Completed	Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes NCT00004787	National Center for Research Resources (NCRR)	Phase 2
Completed	Gene Therapy for the Treatment of Fanconi's Anemia Type C NCT00001399	National Heart, Lung, and Blood Institute (NHLBI)	Phase 1